Life Healthcare (LHC)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 1,255.00 |
|---|---|
| 52-week range | 1,000.00 – 1,302.00 |
| Return, 1 month / 3 months | +4.8% / +16.2% |
| Return, 1 year / 3 years | +4.6% / −35.2% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 27.5% |
| Worst drawdown (1 year) | -20.5% |
| Average daily value traded | 3,354.15M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Life Healthcare is a private healthcare provider based in South Africa. It operates a network of acute care hospitals and related medical facilities, offering surgical, medical and intensive care services to private patients and medical scheme members. The group also provides specialised services such as mental health care, rehabilitation and renal dialysis, and it runs complementary businesses in hospital management and healthcare support. Its hospitals serve communities across South Africa, and the company also has healthcare operations in other countries.
Life Healthcare trades under the code LHC on the Johannesburg Exchange in South Africa, with its price quoted in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Life Healthcare (LHC) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 1,255.00 on 22 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 36 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.6% and over the last three months it rose 16.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.9% | ||
| From 52-week high | -0.9% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 16.2% | ||
| 6-month return | -0.4% | ||
| 12-month return, skipping the last month | -0.3% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.5% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 3,354.15M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.1% |
|---|---|
| 1 month | +4.8% |
| 3 months | +16.2% |
| 6 months | −0.4% |
| 1 year | +4.6% |
| 3 years | −35.2% |
| 5 years | −44.6% |
Signals
| 50-day / 200-day average | 1,186.46 / 1,141.73 |
|---|---|
| Golden / death cross (60 days) | Golden, 27 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 27.79 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Jun 2023 | ZAC 17.0000 |
| 7 Dec 2022 | ZAC 25.0000 |
| 14 Jun 2022 | ZAC 15.0000 |
| 8 Dec 2021 | ZAC 25.0000 |
| 11 Dec 2019 | ZAC 53.0000 |
| 19 Jun 2019 | ZAC 40.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.